[{"id":"79725e7c-a938-4a9e-b556-bf960936b158","acronym":"","url":"https://clinicaltrials.gov/study/NCT03618641","created_at":"2021-09-17T01:53:43.496Z","updated_at":"2025-02-25T16:31:32.025Z","phase":"Phase 2","brief_title":"CMP-001 in Combo With Nivolumab in Stage IIIB/C/D Melanoma Patients With Clinically Apparent Lymph Node Disease","source_id_and_acronym":"NCT03618641","lead_sponsor":"Diwakar Davar","biomarkers":" CD8 • CD4 • SOX10","pipe":"","alterations":" ","tags":["CD8 • CD4 • SOX10"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e Opdivo (nivolumab) • Yervoy (ipilimumab) • vidutolimod (CMP-001)"],"overall_status":"Completed","enrollment":" Enrollment 34","initiation":"Initiation: 08/08/2018","start_date":" 08/08/2018","primary_txt":" Primary completion: 08/20/2020","primary_completion_date":" 08/20/2020","study_txt":" Completion: 12/31/2023","study_completion_date":" 12/31/2023","last_update_posted":"2025-02-07"},{"id":"06d6d872-b4db-4722-a986-805b221dc90d","acronym":"","url":"https://clinicaltrials.gov/study/NCT06599619","created_at":"2025-02-26T07:20:01.996Z","updated_at":"2025-02-26T07:20:01.996Z","phase":"","brief_title":"Effects of Anti-PD1 Adjuvant Checkpoint Blockade Immunotherapy on Atypical/Dysplastic Nevi","source_id_and_acronym":"NCT06599619","lead_sponsor":"John Kirkwood","biomarkers":" BRAF • CD8 • PD-1 • IL6 • IL10 • SOX10","pipe":"","alterations":" ","tags":["BRAF • CD8 • PD-1 • IL6 • IL10 • SOX10"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e Keytruda (pembrolizumab) • Opdivo (nivolumab)"],"overall_status":"Recruiting","enrollment":" Enrollment 30","initiation":"Initiation: 11/01/2024","start_date":" 11/01/2024","primary_txt":" Primary completion: 12/01/2025","primary_completion_date":" 12/01/2025","study_txt":" Completion: 12/01/2025","study_completion_date":" 12/01/2025","last_update_posted":"2024-11-06"},{"id":"59a6af87-be5d-497a-be99-d20aceadb627","acronym":"","url":"https://clinicaltrials.gov/study/NCT05520294","created_at":"2022-08-29T13:03:21.061Z","updated_at":"2024-07-02T16:35:09.309Z","phase":"","brief_title":"Evaluating the Effects of Cannabis Use and Circulating Cannabinoids on Tumor Infiltrating Lymphocytes in Malignant Melanoma","source_id_and_acronym":"NCT05520294","lead_sponsor":"University of Colorado, Denver","biomarkers":" CD20 • CD8 • PD-1 • LAG3 • TIGIT • SOX10 • FOXP3","pipe":"","alterations":" ","tags":["CD20 • CD8 • PD-1 • LAG3 • TIGIT • SOX10 • FOXP3"],"overall_status":"Active, not recruiting","enrollment":" Enrollment 90","initiation":"Initiation: 09/01/2022","start_date":" 09/01/2022","primary_txt":" Primary completion: 08/31/2024","primary_completion_date":" 08/31/2024","study_txt":" Completion: 08/31/2024","study_completion_date":" 08/31/2024","last_update_posted":"2024-04-17"}]